Loblaw sees strong annual profit on steady demand for essentials
Reuters
Published Feb 23, 2023 06:39AM ET
Updated Feb 23, 2023 07:56AM ET
(Reuters) - Loblaw Cos Ltd on Thursday forecast annual earnings above analysts' expectations, after the Canadian retailer's fourth-quarter results beat estimates, helped by strength in its pharmacy business and as demand held up for groceries.
Retailers are leaning on sales of food and medicines as rising prices are forcing consumers to prioritize spending on essentials and trade down to cheaper private-label alternatives from higher-priced brands.
Loblaw posted a 9.7% rise in retail segment sales, reflecting strong growth in its food and drug businesses, with steady demand for cough and cold medicines, high-margin beauty and cosmetics products.
Retail bellwether Walmart (NYSE:WMT) Inc, however, forecast its full-year earnings below estimates on Tuesday, and warned that tight spending by consumers could pressure profit margins.
Loblaw, on the other hand, expects its full-year 2023 adjusted earnings per common share to grow in the low double-digits compared with the average analyst estimate of 9.64%, according to Refinitiv IBES data.
The company's fourth-quarter revenue rose about 10% to C$14.01 billion ($10.35 billion), topping estimates of C$13.75 billion.
On an adjusted basis, Loblaw earned C$1.76 per share, beating analysts' expectations of C$1.71 per share.
($1 = 1.3533 Canadian dollars)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.